Sorafenib, rapamycin, and venetoclax attenuate doxorubicin-induced senescence and promote apoptosis in HCT116 cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sorafenib, rapamycin, and venetoclax attenuate doxorubicin-induced senescence and promote apoptosis in HCT116 cells

Published:2022-01 Issue:1 Volume:30 Page:91-101
ISSN:1319-0164
Container-title:Saudi Pharmaceutical Journal
language:en
Short-container-title:Saudi Pharmaceutical Journal

Author:

As Sobeai Homood M.,Alohaydib Munirah,Alhoshani Ali R.,Alhazzani Khalid,Almutairi Mashal M.,Saleh Tareq,Gewirtz David A.,Alotiabi Moureq R.

Publisher

Elsevier BV

Subject

Pharmaceutical Science,Pharmacology

Reference106 articles.

1. Acceleration of β cell aging determines diabetes and senolysis improves disease outcomes;Aguayo-Mazzucato;Cell Metab.,2019

2. BCL-2 inhibitor venetoclax induces autophagy-associated cell death, cell cycle arrest, and apoptosis in human breast cancer cells;Alhoshani;OncoTargets and Therapy,2020

3. Radiosensitization by PARP inhibition in DNA repair proficient and deficient tumor cells: proliferative recovery in senescent cells;Alotaibi;Radiat. Res.,2016

4. Epidemiology of cancer in Saudi Arabia thru 2010–2019: a systematic review with constrained meta-analysis;Alqahtani;AIMS Public Health,2020

5. Colorectal cancer in Saudi Arabia: incidence, survival, demographics and implications for national policies;Alsanea;Ann. Saudi Med.,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular senescence in cancer: molecular mechanisms and therapeutic targets;MedComm;2024-04-24

2. A Conversation with ChatGPT on Contentious Issues in Senescence and Cancer Research;Molecular Pharmacology;2024-03-08

3. Researching New Drug Combinations with Senolytic Activity Using Senescent Human Lung Fibroblasts MRC-5 Cell Line;Pharmaceuticals;2024-01-04

4. Cellular Senescence and Senolytic Agents: Recent Updates on Their Role and Applications;Current Topics in Medicinal Chemistry;2024-01

5. The Combination of Radiation with PARP Inhibition Enhances Senescence and Sensitivity to the Senolytic, Navitoclax, in Triple Negative Breast Tumor Cells;Biomedicines;2023-11-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3